Latest for Diamond-Blackfan Anemia
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
More about Diamond-Blackfan Anemia
Pathophysiology involves impaired erythroid differentiation with relative sparing of myeloid and megakaryocytic lineages. Approximately 50% of DBA patients have associated physical abnormalities including thumb or radial ray defects, short stature, cardiac defects (especially septal defects), urogenital anomalies, cleft palate, and renal anomalies.
Keep reading about Diamond-Blackfan Anemia
Most patients present before age 2 years with failure to thrive, pallor, and macrocytic anemia. The disorder is characterized by absent or severely reduced erythroid progenitors on bone marrow examination with normal myeloid and megakaryocytic lineages. Fetal hemoglobin (HbF) typically elevated. Diamond-Blackfan patients have significantly increased risk of acute leukemia and solid tumors including osteosarcoma, which requires surveillance. Many patients achieve spontaneous remission in childhood, though relapse possible.
What are the symptoms of Diamond-Blackfan Anemia?
These are common symptoms of Diamond-Blackfan Anemia, and how strong they are varies from person to person.
- Severe anemia presenting by age 1 year
- Fatigue, dyspnea, and pallor
- Physical abnormalities in 50% (thumb defects, short stature)
- Macrocytic anemia
- Absent or severely reduced reticulocyte response
- Normal white blood cells and platelets initially
Who gets Diamond-Blackfan Anemia?
Presents in infancy or early childhood, typically before age 2 years with peak presentation by age 3-6 months. Affects males and females equally. Most cases are autosomal dominant, caused by a change in a ribosomal protein gene. About 45% are inherited from a parent, who has a 50% chance of passing it to each child, and the rest arise as new changes. Rare cases caused by the GATA1 or TSR2 genes affect only boys and pass through mothers who carry the change.
Heterozygous carriers may have mild phenotype. No significant ethnic or racial predisposition identified. Geographic variation in prevalence underexamined. Family history important in approximately half of cases.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Diamond-Blackfan Anemia?
There is currently 1 FDA-approved medication for Diamond-Blackfan Anemia.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Diamond-Blackfan Anemia
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Diamond-Blackfan Anemia resources
Reputable organizations and medical references for learning more about Diamond-Blackfan Anemia, including disease registries, foundation resources, and clinical guidelines.